Radiscan Pathology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 14-12-2024
- Satisfied Charges ₹ 5.66 M
as on 14-12-2024
- Revenue -40.72%
(FY 2023)
- Profit -84.59%
(FY 2023)
- Ebitda -41.92%
(FY 2023)
- Net Worth 8.30%
(FY 2023)
- Total Assets -20.66%
(FY 2023)
About Radiscan Pathology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹5.66 M, as per Ministry of Corporate Affairs (MCA) records.
Gajjar Kaushikkumar, Patel Bhupendra, Shemoli Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110GJ2015PTC082080
- Company No.
082080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Radiscan Pathology?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gajjar Kaushikkumar  | Director | 30-Jan-2015 | Current |
| Patel Bhupendra | Director | 30-Jan-2015 | Current |
| Shemoli Patel | Director | 30-Jan-2015 | Current |
| Gajjar Brijesh | Director | 30-Jan-2015 | Current |
| Masum Bhavsar | Director | 30-Jan-2015 | Current |
| Loma Parikh | Director | 15-Jul-2015 | Current |
Financial Performance of Radiscan Pathology.
Radiscan Pathology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.72% decrease. The company also saw a substantial fall in profitability, with a 84.59% decrease in profit. The company's net worth moved up by a moderate rise of 8.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radiscan Pathology?
Unlock access to Radiscan Pathology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sabarmati Imaging Centre Private LimitedActive 11 years 9 monthsGajjar Kaushikkumar and Patel Bhupendra are mutual person
- Radiscan Imaging Private LimitedActive 11 years 6 months
Gajjar Kaushikkumar and Patel Bhupendra are mutual person
- Radiscan Imaging Shahibaug Private LimitedActive 9 years 4 months
Gajjar Kaushikkumar and Patel Bhupendra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Mar 2017 | ₹2.50 M | Open |
Hdfc Bank Limited Creation Date: 10 Apr 2015 | ₹5.66 M | Satisfied |
How Many Employees Work at Radiscan Pathology?
Unlock and access historical data on people associated with Radiscan Pathology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radiscan Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radiscan Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
